UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Schizophrenia and comorbid cannabis use disorders: Brain structure, function and the effectof antipsychotic medications

Machielsen, M.W.J.

Link to publication

Citation for published version (APA):Machielsen, M. W. J. (2014). Schizophrenia and comorbid cannabis use disorders: Brain structure, function andthe effect of antipsychotic medications. 's-Hertogenbosch: Boxpress.

General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.

Download date: 19 Jul 2020

209

Appendix

References Abel KM, Drake R, Goldstein JM (2010). Sex differences in schizophrenia. Int Rev Psychiatry 22, 417-428

Adriano F, Caltagirone C, Spalletta G (2012). Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia: A Review and Meta-Analysis. The Neuroscientist 18, 180-200

Aharon I, Etcoff N, Ariely D, Chabris CF, O'Connor E, Breiter HC (2001). Beautiful faces have variable reward value: fMRI and behavioral evidence. Neuron 32, 537-551

Akerele E, Levin FR (2007). Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. The American Journal on Addictions 16, 260-268

Albanese MJ, Khantzian EJ, Murphy SL, Green AI (1994). Decreased substance use in chronically psychotic patients treated with clozapine. The American Journal of Psychiatry 151, 780--1

Albanese M, SUH J (2006). Risperidone in cocaine-dependent patients with comorbid psychiatric disorders. Journal of Psychiatric Practice 12, 306-311

Aleman A, Kahn RS, Selten JP (2003). Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry 60, 565-571 &

210

Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE (2010). Long-chain {omega}-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry 67, 146

Amminger G, Schäfer M, Klier C, Slavik J, Holzer I, Holub M, Goldstone S, Whitford T, McGorry P, Berk M (2011). Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals. Molecular psychiatry 17, 1150-1152

Andreasen NC, Flaum M, Arndt S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615-623

Andréasson S, Engström A, Allebeck P, Rydberg U (1987). Cannabis and schizophrenia A longitudinal study of swedish conscripts. The Lancet 330, 1483-1486

Andrews MM, Meda SA, Thomas AD, Potenza MN, Krystal JH, Worhunsky P, Stevens MC, O'Malley S, Book GA, Reynolds B, Pearlson GD (2011). Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biological psychiatry 69, 675-683

Anton RF, Moak DH, Latham PK (1996). The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Archives of General Psychiatry 53, 225-231

Arab L (2003). Biomarkers of fat and fatty acid intake. The Journal of nutrition 133, 925S-932S

Aron A, Fisher H, Mashek DJ, Strong G, Li H, Brown LL (2005). Reward, motivation, and emotion systems associated with early-stage intense romantic love. Journal of neurophysiology 94, 327-337

Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Bmj 325, 1212-1213

Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP (2003). Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological psychiatry 53, 56-64

Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH (2001). Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biological psychiatry 49, 510-522

Assies J, Lok A, Bockting CL, Weverling GJ, Lieverse R, Visser I, Abeling NG, Duran M, Schene AH (2004). Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandins, leukotrienes, and essential fatty acids 70, 349-356

Atkinson CM, Drysdale KA, Fulham WR (2003). Event-related potentials to Stroop and reverse Stroop stimuli. International journal of psychophysiology 47, 1-21

Babin F, Sarda P, Limasset B, Descomps B, Rieu D, Mendy F, de Paulet AC (1993). Nervonic acid in red blood cell sphingomyelin in premature infants: an index of myelin maturation?. Lipids 28, 627-630

Bacon AK, Ham LS (2010). Attention to social threat as a vulnerability to the development of comorbid social anxiety disorder and alcohol use disorders: an avoidance-coping cognitive model. Addictive Behaviors 35, 925-939

Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P (2007). Anterior cingulate volumes in schizophrenia: A systematic review and a meta-analysis of MRI studies. Schizophrenia research 93, 1-12

Baillie AJ, Stapinski L, Crome E, Morley K, Sannibale C, Haber P, Teesson M (2010). Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders. Drug and Alcohol Review 29, 518-524

Band G, Van Boxtel G (1999). Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychologica 101, 179-211

211

Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS (2008). Cannabis use and brain structural alterations in first episode schizophrenia—a region of interest, voxel based morphometric study. Schizophrenia research 99, 1-6

Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ (2008). Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr Drug Abuse Rev 1, 328-339

Bassett DS, Bullmore ET, Meyer-Lindenberg A, Apud JA, Weinberger DR, Coppola R (2009). Cognitive fitness of cost-efficient brain functional networks. Proceedings of the National Academy of Sciences of the United States of America 106, 11747-11752

Beaulieu C (2002). The basis of anisotropic water diffusion in the nervous system - a technical review. NMR in biomedicine 15, 435-455

Beck A, Schlagenhauf F, Wustenberg T, Hein J, Kienast T, Kahnt T, Schmack K, Hagele C, Knutson B, Heinz A, Wrase J (2009). Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biological psychiatry 66, 734-742

Bentsen H, Solberg DK, Refsum H, Gran JM, Bøhmer T, Torjesen PA, Halvorsen O, Lingjærde O (2011). Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder. Biological psychiatry 70, 97-105

Berger GE, Wood SJ, Wellard RM, Proffitt TM, McConchie M, Amminger GP, Jackson GD, Velakoulis D, Pantelis C, McGorry PD (2008). Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology 33, 2467-2473

Berkman ET, Falk EB, Lieberman MD (2011). In the trenches of real-world self-control: neural correlates of breaking the link between craving and smoking. Psychological science 22, 498-506

Bernstein PS, Scheffers MK, Coles MG (1995). "Where did I go wrong?" A psychophysiological analysis of error detection. Journal of experimental psychology.Human perception and performance 21, 1312-1322

Bersani G, Orlandi V, Kotzalidis GD, Pancheri P (2002). Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. European archives of psychiatry and clinical neuroscience 252, 86-92

Bjork JM, Smith AR, Chen G, Hommer DW (2012). Mesolimbic recruitment by nondrug rewards in detoxified alcoholics: effort anticipation, reward anticipation, and reward delivery. Human brain mapping 33, 2174-2188

Bjork JM, Smith AR, Hommer DW (2008). Striatal sensitivity to reward deliveries and omissions in substance dependent patients. NeuroImage 42, 1609-1621

Blood AJ, Zatorre RJ (2001). Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion. Proceedings of the National Academy of Sciences of the United States of America 98, 11818-11823

Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE (2000). Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. Journal of psychoactive drugs 32 Suppl, i-iv, 1-112

Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry research 35, 1-13

Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, Matochik J, Kurian V, Cadet J, Kimes A, Funderburk F, London E (2004). Prefrontal cortical dysfunction in abstinent cocaine abusers. The Journal of neuropsychiatry and clinical neurosciences 16, 456-464

Bongarzone E, Pasquini J, Soto E (1995). Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. Journal of neuroscience research 41, 213-221

Botvinick MM, Cohen JD, Carter CS (2004). Conflict monitoring and anterior cingulate cortex: an update. Trends in cognitive sciences 8, 539-546

&

212

Bourre JM, Pascal G, Durand G, Masson M, Dumont O, Piciotti M (1984). Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. Journal of neurochemistry 43, 342-348

Brady KT, Gray KM, Tolliver BK (2011). Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacology, biochemistry, and behavior 99, 285-294

Brauer LH, De Wit H (1997). High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacology Biochemistry and Behavior 56, 265-272

Brauer LH, de Wit H (1996). Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biological psychiatry 39, 26-32

Brown JW, Braver TS (2005). Learned predictions of error likelihood in the anterior cingulate cortex. Science (New York, N.Y.) 307, 1118-1121

Brunette MF, Drake RE, Xie H, McHugo GJ, Green AI (2006). Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophrenia bulletin 32, 637-643

Brunette MF, Dawson R, O’Keefe CD, Narasimhan M, Noordsy DL, Wojcik J, Green AI (2011). A Randomized Trial of Clozapine Versus Other Antipsychotics for Cannabis Use Disorder in Patients With Schizophrenia. Journal of Dual Diagnosis 7, 50-63

Bryant NL, Buchanan RW, Vladar K, Breier A, Rothman M (1999). Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. The American Journal of Psychiatry 156, 603-609

Buckley m, Peter F (1998). Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. Journal of substance abuse treatment 15, 113-116

Buckley P, Thompson P, Way L, Meltzer HY (1994). Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. American Journal of Psychiatry 151, 385-385

Buhler B, Hambrecht M, Loffler W, an der Heiden W, Hafner H (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia research 54, 243-251

Buhler M, Vollstadt-Klein S, Kobiella A, Budde H, Reed LJ, Braus DF, Buchel C, Smolka MN (2010). Nicotine dependence is characterized by disordered reward processing in a network driving motivation. Biological psychiatry 67, 745-752

Burns MJ (2001). The pharmacology and toxicology of atypical antipsychotic agents. Journal of toxicology.Clinical toxicology 39, 1-14

Bush G, Whalen PJ, Rosen BR, Jenike MA, McInerney SC, Rauch SL (1998). The counting Stroop: an interference task specialized for functional neuroimaging--validation study with functional MRI. Human brain mapping 6, 270-282

Bush G, Whalen PJ, Shin LM, Rauch SL (2006). The counting Stroop: a cognitive interference task. Nature protocols 1, 230-233

Bustamante JC, Barros-Loscertales A, Costumero V, Fuentes-Claramonte P, Rosell-Negre P, Ventura-Campos N, Llopis JJ, Avila C (2013). Abstinence duration modulates striatal functioning during monetary reward processing in cocaine patients. Addiction Biology

Caan MW, Khedoe G, Poot D, den Dekker A, Olabarriaga S, Grimbergen K, van Vliet L, Vos F (2010). Adaptive noise filtering for accurate and precise diffusion estimation in fiber crossings. Medical image computing and computer-assisted intervention 13, 167-174

Cahn W, Hulshoff Pol H, Caspers E, van Haren N, Schnack H, Kahn R (2004). Cannabis and brain morphology in recent-onset schizophrenia. Schizophrenia research 67, 305-307

213

Cantwell R, Brewin J, Glazebrook Cyc, Dalkin T, Fox R, Medley I, Harrison G (1999). Prevalence of substance misuse in first-episode psychosis. The British Journal of Psychiatry 174, 150-153

Carpenter KM, Schreiber E, Church S, McDowell D (2006). Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample. Addictive Behaviors 31, 174-181

Carter BL, Tiffany ST (1999). Meta-analysis of cue-reactivity in addiction research. Addiction 94, 327-340

Caspari D (1999). Cannabis and schizophrenia: results of a follow-up study. European archives of psychiatry and clinical neuroscience 249, 45-49

Chambers CD, Garavan H, Bellgrove MA (2009). Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neuroscience & Biobehavioral Reviews 33, 631-646

Chan RCK, Di X, McAlonan GM, Gong Q (2011). Brain Anatomical Abnormalities in High-Risk Individuals, First-Episode, and Chronic Schizophrenia: An Activation Likelihood Estimation Meta-analysis of Illness Progression. Schizophrenia bulletin 37, 177-188

Chao HH, Luo X, Chang JL, Chiang-shan RL (2009). Activation of the pre-supplementary motor area but not inferior prefrontal cortex in association with short stop signal reaction time–an intra-subject analysis. BMC neuroscience 10, 75

Chase HW, Eickhoff SB, Laird AR, Hogarth L (2011). The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biological psychiatry 70, 785-793

Chen A, Bailey K, Tiernan BN, West R (2011). Neural correlates of stimulus and response interference in a 2-1 mapping stroop task. International journal of psychophysiology 80, 129-138

Cohen M, Solowij N, Carr V (2008). Cannabis, cannabinoids and schizophrenia: integration of the evidence. Australasian Psychiatry 42, 357-368

Cohen HL, Porjesz B, Begleiter H, Wang W (1997). Neurophysiological correlates of response production and inhibition in alcoholics. Alcoholism, Clinical and Experimental Research 21, 1398-1406

Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, Johnston P, Baker A, Schall U (2011). Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 1-11

Colibazzi T, Wexler BE, Bansal R, Hao X, Liu J, Sanchez-Peña J, Corcoran C, Lieberman JA, Peterson BS (2013). Anatomical Abnormalities in Gray and White Matter of the Cortical Surface in Persons with Schizophrenia. PloS one 8, e55783

Colrain IM, Sullivan EV, Ford JM, Mathalon DH, McPherson SL, Roach BJ, Crowley KE, Pfefferbaum A (2011). Frontally mediated inhibitory processing and white matter microstructure: age and alcoholism effects. Psychopharmacology 213, 669-679

Combs DR, Advokat C (2000). Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia. Schizophrenia research 46, 129-137

Compton MT, Furman AC, Kaslow NJ (2004). Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample. Schizophrenia research 71, 61-64

Connolly CG, Foxe JJ, Nierenberg J, Shpaner M, Garavan H (2012). The neurobiology of cognitive control in successful cocaine abstinence. Drug and alcohol dependence 121, 45-53

Corbetta M, Shulman GL (2002). Control of goal-directed and stimulus-driven attention in the brain. Nature reviews.Neuroscience 3, 201-215

Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, Wiers RW (2012). Neural responses associated with cue-reactivity in frequent cannabis users. Addiction Biology 18, 570--80 &

214

Cox WM, Fadardi JS, Pothos EM (2006). The addiction-stroop test: Theoretical considerations and procedural recommendations. Psychological bulletin 132, 443-476

Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke P, Cumming P (2001). Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse 42, 48-53

Dale AM, Fischl B, Sereno MI (1999). Cortical Surface-Based Analysis: I. Segmentation and Surface Reconstruction. NeuroImage 9, 179-194

Dalley J, Everitt B, Robbins T (2011). Impulsivity, Compulsivity, and Top-Down Cognitive Control. Neuron 69, 680-694

Danielmeier C, Ullsperger M (2011). Post-error adjustments. Frontiers in psychology 2, 233

Davidson LL, Heinrichs RW (2003). Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Research: Neuroimaging 122, 69-87

Dawe S, Gullo MJ, Loxton NJ (2004). Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addictive Behaviors 29, 1389-1405

de Greck M, Supady A, Thiemann R, Tempelmann C, Bogerts B, Forschner L, Ploetz KV, Northoff G (2009). Decreased neural activity in reward circuitry during personal reference in abstinent alcoholics--a fMRI study. Human brain mapping 30, 1691-1704

de Haan L, Kapur S (2003). Dopamine, importantie en psychose. Een theorie. Maandblad Geestelijke volksgezondheid 58, 228-235

De Haan L, Weisfelt M, Dingemans P, Linszen D, Wouters L (2002). Psychometric properties of the subjective well-being under neuroleptics scale and the subjective deficit syndrome scale. Psychopharmacology 162, 24-28

de Haan L, Booij J, Lavalaye J, van Amelsvoort T, Linszen D (2006). Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. Psychopharmacology 183, 500-505

de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J (2000). Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. The American Journal of Psychiatry 157, 1019-1020

de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D (2003). Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. The American Journal of Psychiatry 160, 303-309

De La Garza R, Newton TF, Kalechstein AD (2005). Risperidone diminishes cocaine-induced craving. Psychopharmacology 178, 347-350

De Ruiter MB, Oosterlaan J, Veltman DJ, Van den Brink W, Goudriaan AE (2012). Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. Drug and alcohol dependence 121, 81-89

De Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, Van den Brink W (2009). Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers. Neuropsychopharmacology 34, 1027-1038

deCharms RC (2008). Applications of real-time fMRI. Nature reviews.Neuroscience 9, 720-729

Dekker N, de Haan L, van den Berg S, de Gier M, Becker H, Linzen DH (2008). Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. Psychopharmacology bulletin 41, 142-153

Dekker N, Koeter M, Van Den Brink W, GROUP Investigators (2012a). Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale. International journal of methods in psychiatric research 21, 286-300

Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I, GROUP Investigators

215

(2012b). Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychological medicine 42, 1903-1911

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olie JP, Loo H, Krebs MO (2003). Cannabis and schizophrenia: demographic and clinical correlates. L'Encephale 29, 11-17

Dimoska A, Johnstone SJ, Barry RJ (2006). The auditory-evoked N2 and P3 components in the stop-signal task: indices of inhibition, response-conflict or error-detection?. Brain and cognition 62, 98-112

Dixon L, Haas G, Weiden P, Sweeney J, Frances A (1990). Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophrenia bulletin 16, 69

Dixon L (1999). Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia research 35 Suppl, S93-100

Dom G, De Wilde B (2009). Controleverlies. In Handboek verslaving (eds. I. H. A. Franken, W. van den Brink), pp. 209--227. De Tijdstroom Uitgeverij

Dong G, Lu Q, Zhou H, Zhao X (2010). Impulse inhibition in people with internet addiction disorder: electrophysiological evidence from a Go/NoGo study. Neuroscience letters 485, 138-142

Dowd EC, Barch DM (2012). Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia. PLoS One 7, e35622

Drake RE, Xie H, McHugo GJ, Green AI (2000). The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia bulletin 26, 441

Ellison-Wright I, Bullmore E (2010). Anatomy of bipolar disorder and schizophrenia: A meta-analysis. Schizophrenia research 117, 1-12

Eriksen BA, Eriksen CW (1974). Effects of noise letters upon the identification of a target letter in a nonsearch task. Perception & Psychophysics;Perception & Psychophysics 16, 143-149

Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, Muller U, Ooi C, Suckling J, Barnes A, Sahakian BJ (2010). Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Archives of General Psychiatry 67, 632

Ersche K, Sahakian B (2007). The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment. Neuropsychology review 17, 317-336

Esslinger C, Englisch S, Inta D, Rausch F, Schirmbeck F, Mier D, Kirsch P, Meyer-Lindenberg A, Zink M (2012). Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients. Schizophrenia research 140, 114-121

Euser AS, Arends LR, Evans BE, Greaves-Lord K, Huizink AC, Franken IHA (2012). The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: A meta-analytic investigation. Neuroscience & Biobehavioral Reviews 36, 572-603

Euser AS, Evans BE, Greaves-Lord K, Huizink AC, Franken IHA (in press). Diminished error-related brain activity as a promising endophenotype for substance-use disorders: evidence from high-risk offspring. Addiction Biology

Evans DE, Park JY, Maxfield N, Drobes DJ (2009). Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators. Genes, brain, and behavior 8, 86-96

Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP (2003). Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins, leukotrienes, and essential fatty acids 69, 393-399

Exner C, Nehrkorn B, Martin V, Huber M, Shiratori K, Rief W (2008). Sex-dependent hippocampal volume reductions in schizophrenia relate to episodic memory deficits. The Journal of neuropsychiatry and clinical neurosciences 20, 227-230

Falkenstein M (2006). Inhibition, conflict and the Nogo-N2. Clinical neurophysiology 117, 1638-1640 &

216

Falkenstein M, Hoormann J, Christ S, Hohnsbein J (2000). ERP components on reaction errors and their functional significance: a tutorial. Biological psychology 51, 87-107

Falkenstein M, Hoormann J, Hohnsbein J (1999). ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychologica 101, 267-291

Fallgatter AJ, Wiesbeck GA, Weijers HG, Boening J, Strik WK (1998). Event-related correlates of response suppression as indicators of novelty seeking in alcoholics. Alcohol and Alcoholism 33, 475-481

Farren CK, Hameedi FA, Rosen MA, Woods S, Jatlow P, Kosten TR (2000). Significant interaction between clozapine and cocaine in cocaine addicts. Drug and alcohol dependence 59, 153-163

Feil J, Zangen A (2010). Brain stimulation in the study and treatment of addiction. Neuroscience & Biobehavioral Reviews 34, 559-574

Field M, Marhe R, Franken IH (2013a). The clinical relevance of attentional bias in substance use disorders. CNS spectrums, 1-6

Field M, Mogg K, Mann B, Bennett GA, Bradley BP (2013b). Attentional biases in abstinent alcoholics and their association with craving. Psychology of addictive behaviors 27, 71

Field M, Cox WM (2008). Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug and alcohol dependence 97, 1-20

Field M, Munafo MR, Franken IH (2009). A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychological bulletin 135, 589-607

Fischl B, Liu A, Dale AM (2001). Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. Medical Imaging, IEEE Transactions on 20, 70-80

Fischl B, Dale AM (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences 97, 11050-11055

Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002). Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain. Neuron 33, 341-355

Fischl B, Salat DH, van der Kouwe AJW, Makris N, Ségonne F, Quinn BT, Dale AM (2004a). Sequence-independent segmentation of magnetic resonance images. NeuroImage 23, Supplement 1, S69-S84

Fischl B, van der Kouwe A, Destrieux C, Halgren E, Ségonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM (2004b). Automatically Parcellating the Human Cerebral Cortex. Cerebral Cortex 14, 11-22

Fishbein DH, Krupitsky E, Flannery BA, Langevin DJ, Bobashev G, Verbitskaya E, Augustine CB, Bolla KI, Zvartau E, Schech B (2007). Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug and alcohol dependence 90, 25-38

Forman SD, Dougherty GG, Casey BJ, Siegle GJ, Braver TS, Barch DM, Stenger VA, Wick-Hull C, Pisarov LA, Lorensen E (2004). Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biological psychiatry 55, 531-537

Franken IH, Hendriks VM, Stam CJ, Van den Brink W (2004). A role for dopamine in the processing of drug cues in heroin dependent patients. European Neuropsychopharmacology 14, 503-508

Franken IH (2003). Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Progress in neuro-psychopharmacology & biological psychiatry 27, 563-579

Franken IH, Booij J, Van den Brink W (2005). The role of dopamine in human addiction: from reward to motivated attention. European journal of pharmacology 526, 199-206

Franken IH, Hendriksa VM, van den Brink W (2002). Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addictive Behaviors 27, 675-685

Franken IH, Stam CJ, Hendriks VM, van den Brink W (2003). Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence. Psychopharmacology 170, 205-212

217

Franken IH, Van Strien JW, Franzek EJ, Van de Wetering BJ (2007). Error-processing deficits in patients with cocaine dependence. Biological psychology 75, 45-51

Franken IH, Van Strien JW, Kuijpers I (2010). Evidence for a deficit in the salience attribution to errors in smokers. Drug and alcohol dependence 106, 181-185

Frazier JA, Hodge SM, Breeze JL, Giuliano AJ, Terry JE, Moore CM, Kennedy DN, Lopez-Larson MP, Caviness VS, Seidman LJ, Zablotsky B, Makris N (2008). Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophrenia bulletin 34, 37-46

Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD (1996). Detecting activations in PET and fMRI: levels of inference and power. NeuroImage 4, 223-235

Fu L, Bi G, Zou Z, Wang Y, Ye E, Ma L, Ming-Fan, Yang Z (2008). Impaired response inhibition function in abstinent heroin dependents: An fMRI study. Neuroscience letters 438, 322-326

Fusar-Poli P, Berger G (2012). Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies. Journal of clinical psychopharmacology 32, 179-185

Galvan A, Poldrack RA, Baker CM, McGlennen KM, London ED (2011). Neural correlates of response inhibition and cigarette smoking in late adolescence. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 36, 970-978

Garavan H, Hester R, Murphy K, Fassbender C, Kelly C (2006). Individual differences in the functional neuroanatomy of inhibitory control. Brain research 1105, 130-142

Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA (2000). Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. The American Journal of Psychiatry 157, 1789-1798

Gehring WJ, Knight RT (2000). Prefrontal-cingulate interactions in action monitoring. Nature neuroscience 3, 516-520

George TP, Sernyak MJ, Ziedonis DM, Woods SW (1995). Effects of clozapine on smoking in chronic schizophrenic outpatients. Journal of Clinical Psychiatry 56, 344--6

Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008). Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis. Biological psychiatry 64, 774-781

Goh JO, Park DC (2009). Neuroplasticity and cognitive aging: the scaffolding theory of aging and cognition. Restorative Neurology and Neuroscience 27, 391-403

Goldstein RZ, Alia-Klein N, Tomasi D, Carrillo JH, Maloney T, Woicik PA, Wang R, Telang F, Volkow ND (2009). Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proceedings of the National Academy of Sciences of the United States of America 106, 9453-9458

Goldstein RZ, Alia-Klein N, Tomasi D, Zhang L, Cottone LA, Maloney T, Telang F, Caparelli EC, Chang L, Ernst T, Samaras D, Squires NK, Volkow ND (2007). Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction?. The American Journal of Psychiatry 164, 43-51

Goldstein RZ, Craig AD, Bechara A, Garavan H, Childress AR, Paulus MP, Volkow ND (2009). The neurocircuitry of impaired insight in drug addiction. Trends in cognitive sciences 13, 372-380

Goldstein RZ, Tomasi D, Alia-Klein N, Cottone LA, Zhang L, Telang F, Volkow ND (2007). Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers. Drug and alcohol dependence 87, 233-240

Goldstein RZ, Tomasi D, Alia-Klein N, Honorio Carrillo J, Maloney T, Woicik PA, Wang R, Telang F, Volkow ND (2009). Dopaminergic response to drug words in cocaine addiction. The Journal of neuroscience : the official journal of the Society for Neuroscience 29, 6001-6006 &

218

Goldstein RZ, Tomasi D, Rajaram S, Cottone LA, Zhang L, Maloney T, Telang F, Alia-Klein N, Volkow ND (2007). Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 144, 1153-1159

Goldstein RZ, Volkow ND (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nature reviews.Neuroscience 12, 652-669

Gonzalez-Pinto A, Alberich S, Barbeito S, Gutierrez M, Vega P, Ibanez B, Haidar MK, Vieta E, Arango C (2011). Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophrenia bulletin 37, 631-639

Goudriaan AE, Oosterlaan J, De Beurs E, Van Den Brink W (2008). The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychological medicine 38, 41-50

Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, Bailey R (2000). Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. Journal of clinical psychopharmacology 20, 305-310

Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004). Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29, 969-981

Grant JE, Chamberlain SR, Schreiber L, Odlaug BL (2012). Neuropsychological deficits associated with cannabis use in young adults. Drug and alcohol dependence 121, 159-162

Grant JE, Potenza MN, Weinstein A, Gorelick DA (2010). Introduction to behavioral addictions. The American Journal of Drug and Alcohol Abuse 36, 233-241

Grech A, Van Os J, Jones PB, Lewis SW, Murray RM (2005). Cannabis use and outcome of recent onset psychosis. European psychiatry : the journal of the Association of European Psychiatrists 20, 349-353

Green AI, Noordsy DL, Brunette MF, O'Keefe C (2008). Substance abuse and schizophrenia: pharmacotherapeutic intervention. Journal of substance abuse treatment 34, 61-71

Green AI (2005). Schizophrenia and comorbid substance use disorder: effects of antipsychotics. The Journal of clinical psychiatry 66 Suppl 6, 21-26

Green AI, Burgess ES, Dawson R, Zimmet SV, Strous RD (2003). Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophrenia research 60, 81-85

Green AI, Zimmet SV, Strous RD, Schildkraut JJ (1999). Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?. Harvard review of psychiatry 6, 287-296

Green B, Young R, Kavanagh D (2005). Cannabis use and misuse prevalence among people with psychosis. The British journal of psychiatry : 187, 306-313

Gupta N, Basu D (2001). Does risperidone reduce concomitant substance abuse in cases of schizophrenia?. Canadian journal of psychiatry 46, 862-863

Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC (2000). Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Archives of General Psychiatry 57, 761-768

Habets P, Marcelis M, Gronenschild E, Drukker M, van Os J, Genetic Risk and Outcome of Psychosis (G.R.O.U.P) (2011). Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biological psychiatry 69, 487-494

Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS (2012). Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects. Schizophrenia bulletin

Hall WD (2006). Cannabis use and the mental health of young people. Australian and New Zealand Journal of Psychiatry 40, 105-113

219

Hambrecht M, Häfner H (2000). Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Australian and New Zealand Journal of Psychiatry 34, 468-475

Hampshire A, Chamberlain SR, Monti MM, Duncan J, Owen AM (2010). The role of the right inferior frontal gyrus: inhibition and attentional control. NeuroImage 50, 1313-1319

Heinz A, Schlagenhauf F (2010). Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophrenia bulletin 36, 472-485

Heinz A, Wrase J, Kahnt T, Beck A, Bromand Z, Grusser SM, Kienast T, Smolka MN, Flor H, Mann K (2007). Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcoholism, Clinical and Experimental Research 31, 1138-1147

Heishman SJ, Evans RJ, Singleton EG, Levin KH, Copersino ML, Gorelick DA (2009). Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug and alcohol dependence 102, 35-40

Hendrick OM, Luo X, Zhang S, Li CS (2012). Saliency processing and obesity: a preliminary imaging study of the stop signal task. Obesity (Silver Spring, Md.) 20, 1796-1802

Herrmann MJ, Rommler J, Ehlis AC, Heidrich A, Fallgatter AJ (2004). Source localization (LORETA) of the error-related-negativity (ERN/Ne) and positivity (Pe). Brain research.Cognitive brain research 20, 294-299

Hester R, Fassbender C, Garavan H (2004). Individual differences in error processing: a review and reanalysis of three event-related fMRI studies using the GO/NOGO task. Cerebral cortex 14, 986-994

Hester R, Garavan H (2009). Neural mechanisms underlying drug-related cue distraction in active cocaine users. Pharmacology, biochemistry, and behavior 93, 270-277

Hester R, Garavan H (2004). Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. The Journal of neuroscience 24, 11017-11022

Hester R, Nestor L, Garavan H (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34, 2450-2458

Hewig J, Coles MGH, Trippe RH, Hecht H, Miltner WHR (2011). Dissociation of Pe and ERN/Ne in the conscious recognition of an error. Psychophysiology, no-no

Hibbeln JR, Makino KK, Martin CE, Dickerson F, Boronow J, Fenton WS (2003). Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biological psychiatry 53, 431-441

Highley JR, Esiri MM, McDonald B, Cortina-Borja M, Herron BM, Crow TJ (1999). The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain 122, 99-110

Hill SK, Reilly JL, Harris MSH, Rosen C, Marvin RW, DeLeon O, Sweeney JA (2009). A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia. Schizophrenia research 113, 167-175

Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, Malhotra AK (2004). Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. American Journal of Human Genetics 75, 862-872

Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD (2002). Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochemical research 27, 1193-1200

Hofling AA, Kim JH, Fantz CR, Sands MS, Song SK (2009). Diffusion tensor imaging detects axonal injury and demyelination in the spinal cord and cranial nerves of a murine model of globoid cell leukodystrophy. NMR in biomedicine 22, 1100-1106

Houben K, Nederkoorn C, Wiers RW, Jansen A (2011). Resisting temptation: Decreasing alcohol-related affect and drinking behavior by training response inhibition. Drug and alcohol dependence 116, 132-136

&

220

Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S (2012). The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Archives of General Psychiatry 69, 776-786

Huster R, Westerhausen R, Pantev C, Konrad C (2010). The role of the cingulate cortex as neural generator of the N200 and P300 in a tactile response inhibition task. Human brain mapping 31, 1260-1271

Irving C, Mumby-Croft R, Joy L (2006). Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database Syst Rev 3

Jager G, Block RI, Luijten M, Ramsey NF (2013). Tentative Evidence for Striatal Hyperactivity in Adolescent Cannabis-Using Boys: A Cross-Sectional Multicenter fMRI Study. Journal of psychoactive drugs 45, 156-167

Jager G, Ramsey NF (2008). Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Current drug abuse reviews 1, 114-123

James A, James C, Thwaites T (2013). The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry Research: Neuroimaging

James A, Hough M, James S, Winmill L, Burge L, Nijhawan S, Matthews PM, Zarei M (2011). Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophrenia research 128, 91-97

Janes AC, Pizzagalli DA, Richardt S, Frederick Bde B, Holmes AJ, Sousa J, Fava M, Evins AE, Kaufman MJ (2010). Neural substrates of attentional bias for smoking-related cues: an FMRI study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 35, 2339-2345

Jentsch JD, Taylor JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology 146, 373-390

Jia Z, Worhunsky PD, Carroll KM, Rounsaville BJ, Stevens MC, Pearlson GD, Potenza MN (2011). An Initial Study of Neural Responses to Monetary Incentives as Related to Treatment Outcome in Cocaine Dependence. Biological psychiatry 70, 553-560

Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, MacFall J, Fischl B, Dale A (2006). Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data. NeuroImage 30, 436-443

Juckel G, Schlagenhauf F, Koslowski M, Wustenberg T, Villringer A, Knutson B, Wrase J, Heinz A (2006). Dysfunction of ventral striatal reward prediction in schizophrenia. NeuroImage 29, 409-416

Kaiser S, Unger J, Kiefer M, Markela J, Mundt C, Weisbrod M (2003). Executive control deficit in depression: event-related potentials in a Go/Nogo task. Psychiatry research 122, 169-184

Kamarajan C, Porjesz B, Jones KA, Choi K, Chorlian DB, Padmanabhapillai A, Rangaswamy M, Stimus AT, Begleiter H (2005). Alcoholism is a disinhibitory disorder: neurophysiological evidence from a Go/No-Go task. Biological psychology 69, 353-373

Kapur S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 160, 13-23

Kapur S, Seeman P (2001). Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. American Journal of Psychiatry 158, 360-369

Karch S, Graz C, Jager L, Karamatskos E, Flatz AS, Lutz J, Holtschmidt-Taschner B, Genius J, Reiser GL, Moller HJ, Hegerl U, Soyka M, Mulert C (2007). Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism. Clinical EEG and neuroscience 38, 89-95

Karch S, Jager L, Karamatskos E, Graz C, Stammel A, Flatz W, Lutz J, Holtschmidt-Taschner B, Genius J, Leicht G, Pogarell O, Born C, Moller HJ, Hegerl U, Reiser M, Soyka M, Mulert C (2008). Influence of trait

221

anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses. Journal of psychiatric research 42, 734-745

Kaufman JN, Ross TJ, Stein EA, Garavan H (2003). Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. The Journal of neuroscience : the official journal of the Society for Neuroscience 23, 7839-7843

Kaune M, Williams J, Ziedonis D (2002). Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry 47, 671-675

Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia bulletin 13, 261-276

Kerns JG, Cohen JD, MacDonald AW, Cho RY, Stenger VA, Carter CS (2004). Anterior Cingulate Conflict Monitoring and Adjustments in Control. Science 303, 1023-1026

Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP (2002). Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia research 58, 1-10

Khantzian EJ (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard review of psychiatry 4, 231-244

Khantzian EJ (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. The American Journal of Psychiatry 142, 1259-1264

Kim JH, Kim D, Marder SR (2008). Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 984-988

Kim SH, Han DH, Joo SY, Min KJ (2010). The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. Human psychopharmacology 25, 187-190

Kirkpatrick B, Amador XF, Flaum M, Yale SA, Gorman JM, Carpenter Jr WT, Tohen M, McGlashan T (1996). The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse. Schizophrenia research 20, 69-77

Knutson B, Fong GW, Adams CM, Varner JL, Hommer D (2001). Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 12, 3683-3687

Kok A, Ramautar JR, De Ruiter MB, Band GPH, Ridderinkhof KR (2004). ERP components associated with successful and unsuccessful stopping in a stop-signal task. Psychophysiology 41, 9-20

Kristensen K, Cadenhead KS (2007). Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry research 151, 151-154

Kuhn S, Gallinat J (2011). Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response. The European journal of neuroscience 33, 1318-1326

Kumra S, Robinson P, Tambyraja R, Jensen D, Schimunek C, Houri A, Reis T, Lim K (2012). Parietal Lobe Volume Deficits in Adolescents With Schizophrenia and Adolescents With Cannabis Use Disorders. Journal of the American Academy of Child & Adolescent Psychiatry 51, 171-180

Kuroki T, Nagao N, Nakahara T (2008). Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Progress in brain research 172, 199-212

Lacadie CM, Fulbright RK, Rajeevan N, Constable RT, Papademetris X (2008). More accurate Talairach coordinates for neuroimaging using non-linear registration. NeuroImage 42, 717-725

Lang PJ, Bradley MM, Cuthbert BN (2008). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. University of Florida, Gainesville, FL.

Larson MJ, Kaufman DA, Perlstein WM (2009). Neural time course of conflict adaptation effects on the Stroop task. Neuropsychologia 47, 663-670 &

222

Lataster J, van Os J, de Haan L, Thewissen V, Bak M, Lataster T, Lardinois M, Delespaul P, Myin-Germeys I (2011). Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study. The Journal of clinical psychiatry 72, 1397-1404

Lavric A, Pizzagalli DA, Forstmeier S (2004). When 'go' and 'nogo' are equally frequent: ERP components and cortical tomography. The European journal of neuroscience 20, 2483-2488

Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L (2009). Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology 207, 163-172

Leland DS, Arce E, Miller DA, Paulus MP (2008). Anterior cingulate cortex and benefit of predictive cueing on response inhibition in stimulant dependent individuals. Biological psychiatry 63, 184-190

Lessov-Schlaggar CN, Lepore RL, Kristjansson SD, Schlaggar BL, Barnes KA, Petersen SE, Madden PA, Heath AC, Barch DM (2013). Functional neuroimaging study in identical twin pairs discordant for regular cigarette smoking. Addiction Biology 18, 98-108

Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM (2012). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane database of systematic reviews (Online) 5, CD008016

Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV (1999). Pergolide mesylate for cocaine abuse: a controlled preliminary trial. The American Journal on Addictions 8, 120-127

Levitt JJ, Bobrow L, Lucia D, Srinivasan P (2010). A Selective Review of Volumetric and Morphometric Imaging in Schizophrenia. In Behavioral Neurobiology of Schizophrenia and Its Treatmentpp. 243-281. Springer Berlin Heidelberg

Li W, van Tol M, Li M, Miao W, Jiao Y, Heinze H, Bogerts B, He H, Walter M (2012a). Regional specificity of sex effects on subcortical volumes across the lifespan in healthy aging. Human brain mapping

Li X, Alapati V, Jackson C, Xia S, Bertisch HC, Branch CA, DeLisi LE (2012b). Structural abnormalities in language circuits in genetic high-risk subjects and schizophrenia patients. Psychiatry Research: Neuroimaging 201, 182-189

Li CS, Huang C, Constable RT, Sinha R (2006). Imaging response inhibition in a stop-signal task: neural correlates independent of signal monitoring and post-response processing. The Journal of neuroscience 26, 186-192

Li CS, Huang C, Yan P, Bhagwagar Z, Milivojevic V, Sinha R (2008). Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology 33, 1798-1806

Li CS, Luo X, Yan P, Bergquist K, Sinha R (2009). Altered impulse control in alcohol dependence: neural measures of stop signal performance. Alcoholism, Clinical and Experimental Research 33, 740-750

Li CS, Morgan PT, Matuskey D, Abdelghany O, Luo X, Chang JL, Rounsaville BJ, Ding YS, Malison RT (2010). Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proceedings of the National Academy of Sciences of the United States of America 107, 14455-14459

Li CS, Yan P, Sinha R, Lee TW (2008). Subcortical processes of motor response inhibition during a stop signal task. NeuroImage 41, 1352-1363

Li D, Collier DA, He L (2006). Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Human molecular genetics 15, 1995-2002

Linszen DH, Dingemans PM, Lenior ME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273-279

Littel M, van den Berg I, Luijten M, van Rooij AJ, Keemink L, Franken IHA (2012). Error processing and response inhibition in excessive computer game players: an event-related potential study. Addiction Biology 17, 934-947

223

Liu X, Hairston J, Schrier M, Fan J (2011). Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neuroscience & Biobehavioral Reviews 35, 1219-1236

Lock J, Garrett A, Beenhakker J, Reiss AL (2011). Aberrant brain activation during a response inhibition task in adolescent eating disorder subtypes. The American Journal of Psychiatry 168, 55-64

Loebl T, Angarita GA, Pachas GN, Huang K, Lee SH, Nino J, Logvinenko T, Culhane MA, EDEN EVINS A (2008). A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men. The Journal of clinical psychiatry 69, 480-486

Logan GD, Cowan WB, Davis KA (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. Journal of experimental psychology.Human perception and performance 10, 276-291

Lorenzetti V, Solowij N, Fornito A, Lubman D, Yucel M (2013). The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature. Current pharmaceutical design

Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yücel M (2010). Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?. Subst Use Misuse 45, 1787-1808

Lubman DI, King JA, Castle DJ (2010). Treating comorbid substance use disorders in schizophrenia. International review of psychiatry 22, 191-201

Lubman DI, Yucel M, Pantelis C (2004). Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction 99, 1491-1502

Luijten M, Littel M, Franken IHA (2011a). Deficits in Inhibitory Control in Smokers During a Go/NoGo Task: An Investigation Using Event-Related Brain Potentials. Plos One 6, e18898

Luijten M, Van Meel CS, Franken IHA (2011b). Diminished error processing in smokers during smoking cue exposure. Pharmacology Biochemistry and Behavior 97, 514-520

Luijten M, Veltman DJ, Hester R, Smits M, Pepplinkhuizen L, Franken IH (2012). Brain activation associated with attentional bias in smokers is modulated by a dopamine antagonist. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 37, 2772-2779

Luijten M, Veltman DJ, van den Brink W, Hester R, Field M, Smits M, Franken IH (2011). Neurobiological substrate of smoking-related attentional bias. NeuroImage 54, 2374-2381

Luijten M, Veltman DJ, Hester R, Smits M, Nijs IMT, Pepplinkhuizen L, Franken IHA (2012). The role of dopamine in inhibitory control in smokers and non-smokers: A pharmacological fMRI study. European Neuropsychopharmacology

Luo X, Zhang S, Hu S, Bednarski SR, Erdman E, Farr OM, Hong K, Sinha R, Mazure CM, Chiang-shan RL (2013). Error processing and gender-shared and-specific neural predictors of relapse in cocaine dependence. Brain 136, 1231-1244

Lysaker P, Bell M, Beam-Goulet J, Milstein R (1994). Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. The Journal of nervous and mental disease 182, 109-112

Machielsen M, Beduin AS, Dekker N, Genetic Risk and Outcome of Psychosis (GROUP) investigators (2012). Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of psychopharmacology 26, 189-195

Machielsen M, van der Sluis S, de Haan L (2010). Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms. The Australian and New Zealand Journal of Psychiatry 44, 721-728

Machielsen MW, de Haan L (2009). Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmission. Psychopharmacology bulletin 42, 40-52 &

224

Machielsen MWJ, Koenders L, Vingerhoets WAM, Van Gasselt ACM, Heering HD, Meijer CJ, Caan MWA, Groot PFC, Van den Brink W, Koeter MWJ, Nederveen AJ, Majoie CBLM, Shahand S, Olabarriaga SD, Cousijn J, Den Braber A, De Geus EJC, Boomsma DI, Van ‘t Ent D, Rive MM, De Ruiter MB, Van de Giessen E, Huyser C, Bloemen OJN, Peters B, De Kwaasteniet BP, Schmaal L, Van Holst RJ, Da Silva Alves F, Van Tol MJ, De Haan L, De Haan L Brain Volume, Cortical Thickness and Cortical Surface Area in Recent Onset Schizophrenia, submitted

Magno E, Foxe JJ, Molholm S, Robertson IH, Garavan H (2006). The anterior cingulate and error avoidance. The Journal of neuroscience 26, 4769-4773

Mahon K, Burdick KE, Szeszko PR (2010). A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neuroscience & Biobehavioral Reviews 34, 533-554

Maia TV, Frank MJ (2011). From reinforcement learning models to psychiatric and neurological disorders. Nature neuroscience 14, 154-162

Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T (2012). Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. European archives of psychiatry and clinical neuroscience 263, 1-11

Malone DT, Hill MN, Rubino T (2010). Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. British journal of pharmacology 160, 511-522

Marcus P, Snyder R (1995). Reduction of comorbid substance abuse with clozapine. The American Journal of Psychiatry 152, 959

Marhe R, Luijten M, van de Wetering BJ, Smits M, Franken IH (2013a). Individual Differences in Anterior Cingulate Activation Associated with Attentional Bias Predict Cocaine Use After Treatment. Neuropsychopharmacology 38, 1085-1093

Marhe R, van de Wetering BJM, Franken IHA (2013b). Error-Related Brain Activity Predicts Cocaine Use After Treatment at 3-Month Follow-up. Biological psychiatry 73, 782-788

Marissen MA, Franken IH, Blanken P, van den Brink W, Hendriks VM (2006a). The relation between social desirability and different measures of heroin craving. Journal of addictive diseases 24, 91-103

Marissen MA, Franken IH, Waters AJ, Blanken P, van den Brink W, Hendriks VM (2006b). Attentional bias predicts heroin relapse following treatment. Addiction (Abingdon, England) 101, 1306-1312

Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M (2004). Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29, 1190-1202

Martin-Soelch C, Chevalley AF, Kunig G, Missimer J, Magyar S, Mino A, Schultz W, Leenders KL (2001). Changes in reward-induced brain activation in opiate addicts. The European journal of neuroscience 14, 1360-1368

Mathalon DH, Pfefferbaum A, Lim KO, Rosenbloom MJ, Sullivan EV (2003). Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Archives of General Psychiatry 60, 245

McEvoy JP, Freudenreich O, Levin ED, Rose JE (1995). Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119, 124-126

McEvoy JP, Freudenreich O, Wilson WH (1999). Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological psychiatry 46, 125-129

McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J (1995). Clozapine decreases smoking in patients with chronic schizophrenia. Biological psychiatry 37, 550-552

McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921

225

McGrath J, Saha S, Chant D, Welham J (2008). Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality. Epidemiologic reviews 30, 67-76

McHugh RK, Hearon BA, Otto MW (2010). Cognitive behavioral therapy for substance use disorders. The Psychiatric clinics of North America 33, 511-525

McNamara RK, Jandacek R, Rider T, Tso P, Stanford KE, Hahn C, Richtand NM (2008). Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry research 160, 285-299

Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, Tapert SF (2009). IMAGING STUDY: Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addiction Biology 14, 457-468

Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, McDonald K, Ward A, Poulton R, Moffitt TE (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences 109, E2657-E2664

Meijer J, Simons CJ, Quee PJ, Verweij K (2012a). Cognitive alterations in patients with non‐affective psychotic disorder and their unaffected siblings and parents. Acta Psychiatrica Scandinavica 125, 66-76

Meijer JH, Dekker N, Koeter M, Quee PJ, Van Beveren N, Meijer CJ (2012b). Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychol.Med 42, 705-716

Meltzer HY (2012). Clozapine: balancing safety with superior antipsychotic efficacy. Clinical schizophrenia & related psychoses 6, 134-144

Menon V, Adleman NE, White CD, Glover GH, Reiss AL (2001). Error-related brain activation during a Go/NoGo response inhibition task. Human brain mapping 12, 131-143

Meredith CW, Jaffe C, Yanasak E, Cherrier M, Saxon AJ (2007). An open-label pilot study of risperidone in the treatment of methamphetamine dependence. Journal of psychoactive drugs 39, 167-172

Meseguer V, Romero MJ, Barros-Loscertales A, Belloch V, Bosch-Morell F, Romero J, Avila C (2007). Mapping the apetitive and aversive systems with emotional pictures using a block-design fMRI procedure. Psicothema 19, 483-488

Miller R, Wickens J, Beninger R (1990). Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Progress in neurobiology 34, 143-183

Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, Woods SW (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 159, 863-865

Miltner WH, Lemke U, Weiss T, Holroyd C, Scheffers MK, Coles MG (2003). Implementation of error-processing in the human anterior cingulate cortex: a source analysis of the magnetic equivalent of the error-related negativity. Biological psychology 64, 157-166

Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC (2009). Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Archives of General Psychiatry 66, 811-822

Mizrahi R, Mamo D, Rusjan P, Graff A, Houle S, Kapur S (2009). The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 12, 715-721

Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S (2007). Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. The American Journal of Psychiatry 164, 630-637

&

226

Mobbs D, Greicius MD, Abdel-Azim E, Menon V, Reiss AL (2003). Humor modulates the mesolimbic reward centers. Neuron 40, 1041-1048

Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319-328

Mostofsky SH, Simmonds DJ (2008). Response inhibition and response selection: two sides of the same coin. Journal of cognitive neuroscience 20, 751-761

Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990). Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia bulletin 16, 31-56

Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, Jones PB, Bullmore ET, Robbins TW, Fletcher PC (2008). Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Molecular psychiatry 13, 239, 267-76

Naber D (1995). A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International clinical psychopharmacology

Naqvi NH, Bechara A (2010). The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain structure & function 214, 435-450

Narr KL, Bilder RM, Toga AW, Woods RP, Rex DE, Szeszko PR, Robinson D, Sevy S, Gunduz-Bruce H, Wang Y, DeLuca H, Thompson PM (June 2005). Mapping Cortical Thickness and Gray Matter Concentration in First Episode Schizophrenia. Cerebral Cortex 15, 708-719

Nasrallah HA, Schwarzkopf SB, Olson SC, Coffman JA (1990). Gender differences in schizophrenia on MRI brain scans. Schizophrenia bulletin 16, 205-210

Nestor L, Hester R, Garavan H (2010). Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage 49, 1133-1143

Nestor L, McCabe E, Jones J, Clancy L, Garavan H (2011). Differences in "bottom-up" and "top-down" neural activity in current and former cigarette smokers: Evidence for neural substrates which may promote nicotine abstinence through increased cognitive control. NeuroImage 56, 2258-2275

Newton TF, Ling W, Kalechstein AD, Uslaner J, Tervo K (2001). Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry research 102, 227-233

Nielsen MO, Rostrup E, Wulff S, Bak N, Broberg BV, Lublin H, Kapur S, Glenthoj B (2012). Improvement of Brain Reward Abnormalities by Antipsychotic Monotherapy in Schizophrenia. Archives of General Psychiatry, 1-10

Nieuwenhuis S, Yeung N, Van den Wildenberg W, Ridderinkhof KR (2003). Electrophysiological correlates of anterior cingulate function in a go/no-go task: effects of response conflict and trial type frequency. Cognitive, affective & behavioral neuroscience 3, 17-26

Nieuwenhuis S, Ridderinkhof KR, Blom J, Band GPH, Kok A (2001). Error-related brain potentials are differentially related to awareness of response errors: Evidence from an antisaccade task. Psychophysiology 38, 752-760

Nigg JT (2000). On Inhibition/Disinhibition in Developmental Psychopathology: Views From Cognitive and Personality Psychology and a Working Inhibition Taxonomy,. Psychological bulletin 126, 220-246

Noël X, Van der Linden M, d’Acremont M, Bechara A, Dan B, Hanak C, Verbanck P (2007). Alcohol cues increase cognitive impulsivity in individuals with alcoholism. Psychopharmacology 192, 291-298

Nordvik I, Myhr KM, Nyland H, Bjerve KS (2000). Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurologica Scandinavica 102, 143-149

O'Brien JS (1964). A molecular defect of myelination. Biochemical and biophysical research communications 15, 484-490

227

Olabarriaga SD, Glatard T, de Boer PT (2010). A virtual laboratory for medical image analysis. IEEE transactions on information technology in biomedicine 14, 979-985

Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM (2011). Are There Progressive Brain Changes in Schizophrenia? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies. Biological psychiatry 70, 88-96

Olvet DM, Hajcak G (2008). The error-related negativity (ERN) and psychopathology: toward an endophenotype. Clinical psychology review 28, 1343-1354

Oscar-Berman M, Marinkovic K (2007). Alcohol: effects on neurobehavioral functions and the brain. Neuropsychology review 17, 239-257

Overbeek TJM, Nieuwenhuis S, Ridderinkhof KR (2005). Dissociable Components of Error Processing: On the Functional Significance of the Pe Vis-à-vis the ERN/Ne. Journal of Psychophysiology 19, 319-329

Padilla ML, Colrain IM, Sullivan EV, Mayer BZ, Turlington SR, Hoffman LR, Wagstaff AE, Pfefferbaum A (2011). Electrophysiological evidence of enhanced performance monitoring in recently abstinent alcoholic men. Psychopharmacology 213, 81-91

Palaniyappan L, Liddle PF (2012). Differential effects of surface area, gyrification and cortical thickness on voxel based morphometric deficits in schizophrenia. NeuroImage 60, 693-699

Pandey AK, Kamarajan C, Tang Y, Chorlian DB, Roopesh BN, Manz N, Stimus A, Rangaswamy M, Porjesz B (2012). Neurocognitive deficits in male alcoholics: An ERP/sLORETA analysis of the N2 component in an equal probability Go/NoGo task. Biological psychology 89, 170-182

Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, Jacobson K, Lyons MJ, Grant MD, Franz CE (2009). Distinct genetic influences on cortical surface area and cortical thickness. Cerebral Cortex 19, 2728-2735

Patel KT, Stevens MC, Meda SA, Muska C, Thomas AD, Potenza MN, Pearlson GD (2013). Robust Changes in Reward Circuitry During Reward Loss in Current and Former Cocaine Users During Performance of a Monetary Incentive Delay Task. Biological psychiatry

Peralta V, Cuesta MJ (1992). Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatrica Scandinavica 85, 127-130

Perlstein WM, Carter CS, Noll DC, Cohen JD (2001). Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. The American Journal of Psychiatry 158, 1105-1113

Peters B, Duran M, Vlieger E, Majoie C, den Heeten G, Linszen D, de Haan L (2009). Polyunsaturated fatty acids and brain white matter anisotropy in recent-onset schizophrenia: A preliminary study. Prostaglandins, Leukotrienes and Essential Fatty Acids 81, 61-63

Peters BD, Blaas J, de Haan L (2010). Diffusion tensor imaging in the early phase of schizophrenia: What have we learned?. Journal of psychiatric research 44, 993-1004

Peters J, Bromberg U, Schneider S, Brassen S, Menz M, Banaschewski T, Conrod PJ, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Smolka M, Strohle A, Struve M, Loth E, Schumann G, Buchel C, IMAGEN Consortium (2011). Lower ventral striatal activation during reward anticipation in adolescent smokers. The American Journal of Psychiatry 168, 540-549

Pfefferbaum A, Rosenbloom M, Ford JM (1987). Late event-related potential changes in alcoholics. Alcohol 4, 275-281

Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD (2002). Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. The Australian and New Zealand Journal of Psychiatry 36, 800-806

&

228

Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J (1996). Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients. The American Journal of Psychiatry 153, 1571-1578

Potenza MN (2006). Should addictive disorders include non-substance-related conditions?. Addiction 101 Suppl 1, 142-151

Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, Skudlarski P, Gore JC (2003). An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. The American Journal of Psychiatry 160, 1990-1994

Potvin S, Mancini-Marïe A, Fahim C, Mensour B, Lévesque J, Karama S, Beauregard M, Rompré P, Stip E (2007). Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Research: Neuroimaging 154, 275-279

Potvin S, Sepehry AA, Stip E (2006). A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological medicine 36, 431-440

Procyshyn RM, Tse G, Sin O, Flynn S (2002). Concomitant clozapine reduces smoking in patients treated with risperidone. European neuropsychopharmacology 12, 77-80

Procyshyn R, Ihsan N, Thompson D (2001). A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics. International clinical psychopharmacology 16, 291-294

Puri BK (2010). Progressive structural brain changes in schizophrenia. Expert review of neurotherapeutics 10, 33-42

Rabbitt PM (1966). Error correction time without external error signals. Nature 212, 438

Rais M, van Haren NEM, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS (2010). Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European Neuropsychopharmacology 20, 855-865

Rakic P (1988). Specification of cerebral cortical areas. Science 241, 170-176

Ramautar JR, Kok A, Ridderinkhof KR (2006). Effects of stop-signal modality on the N2/P3 complex elicited in the stop-signal paradigm. Biological psychology 72, 96-109

Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W (2006). A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 101, 267-274

Raznahan A, Shaw P, Lalonde F, Stockman M, Wallace GL, Greenstein D, Clasen L, Gogtay N, Giedd JN (2011). How does your cortex grow?. The Journal of Neuroscience 31, 7174-7177

Reddy RD, Keshavan MS, Yao JK (2004). Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophrenia bulletin 30, 901-911

Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264, 2511-2518

Reuter M, Rosas HD, Fischl B (2010). Highly accurate inverse consistent registration: A robust approach. NeuroImage 53, 1181-1196

Richardson AJ, Allen SJ, Hajnal JV, Cox IJ, Easton T, Puri BK (2001). Associations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25, 1513-1521

Ridderinkhof KR, Ramautar JR, Wijnen JG (2009). To P(E) or not to P(E): a P3-like ERP component reflecting the processing of response errors. Psychophysiology 46, 531-538

Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S (2004a). The role of the medial frontal cortex in cognitive control. Science 306, 443-447

229

Ridderinkhof KR, Van den Wildenberg WP, Segalowitz SJ, Carter CS (2004b). Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain and cognition 56, 129-140

Rimol LM, Nesvag R, Hagler DJ,Jr, Bergmann O, Fennema-Notestine C, Hartberg CB, Haukvik UK, Lange E, Pung CJ, Server A, Melle I, Andreassen OA, Agartz I, Dale AM (2012). Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biological psychiatry 71, 552-560

Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA (1988). The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry 45, 1069-1077

Robinson TE, Berridge KC (2008). Review. The incentive sensitization theory of addiction: some current issues. Philosophical transactions of the Royal Society of London.Series B, Biological sciences 363, 3137-3146

Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain research.Brain research reviews 18, 247-291

Roesch-Ely D, Scheffel H, Weiland S, Schwaninger M, Hundemer HP, Kolter T, Weisbrod M (2005). Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology 178, 420-430

Roy A, Roy M, Smelson DA (1998). Risperidone, ERG, and cocaine craving. The American Journal on Addictions 7, 90-90

Rubio G, Martínez I, Ponce G, Jiménez-Arriero MA, López-Muñoz F, Álamo C (2006). Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. Canadian journal of psychiatry 51, 531

Rubio G, Jimenez M, Rodriguez-Jimenez R, Martinez I, Avila C, Ferre F, Jimenez-Arriero MA, Ponce G, Palomo T (2008). The role of behavioral impulsivity in the development of alcohol dependence: a 4-year follow-up study. Alcoholism, Clinical and Experimental Research 32, 1681-1687

Rush CR, Stoops WW, Hays LR, Glaser PE, Hays LS (2003). Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. Journal of Pharmacology and Experimental Therapeutics 306, 195-204

Salo R, Ursu S, Buonocore MH, Leamon MH, Carter C (2009). Impaired Prefrontal Cortical Function and Disrupted Adaptive Cognitive Control in Methamphetamine Abusers: A Functional Magnetic Resonance Imaging Study. Biological psychiatry 65, 706-709

Salvati S, Natali F, Attorri L, Di Benedetto R, Leonardi F, Di Biase A, Ferri F, Fortuna S, Lorenzini P, Sanchez M, Ricceri L, Vitelli L (2008). Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. Journal of neuroscience research 86, 776-784

Sankoh AJ, Huque MF, Dubey SD (1997). Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Statistics in medicine 16, 2529-2542

Sastry PS (1985). Lipids of nervous tissue: composition and metabolism. Progress in lipid research 24, 69-176

Sayette MA, Shiffman S, Tiffany ST, Niaura RS, Martin CS, Schadel WG (2000). The measurement of drug craving. Addiction 95, 189-210

Schaub M, Fanghaenel K, Stohler R (2008). Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand Journal of Psychiatry 42, 1060-1065

Schellekens AF, De Bruijn ER, Van Lankveld CA, Hulstijn W, Buitelaar JK, De Jong CA, Verkes RJ (2010). Alcohol dependence and anxiety increase error-related brain activity. Addiction 105, 1928-1934

Scheller-Gilkey G, Thomas SM, Woolwine BJ, Miller AH (2002). Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia. Schizophrenia bulletin 28, 223-231

Scherk H, Falkai P (2006). Effects of antipsychotics on brain structure. Current Opinion in Psychiatry 19, 145-150 &

230

Schlagenhauf F, Juckel G, Koslowski M, Kahnt T, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2008). Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 196, 673-684

Schlagenhauf F, Sterzer P, Schmack K, Ballmaier M, Rapp M, Wrase J, Juckel G, Gallinat J, Heinz A (2009). Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biological psychiatry 65, 1032-1039

Schmaal L, Joos L, Koeleman M, Veltman DJ, van den Brink W, Goudriaan AE (2012). Effects of Modafinil on Neural Correlates of Response Inhibition in Alcohol-Dependent Patients. Biological psychiatry 73, 211-218

Schnell T, Kleiman A, Gouzoulis-Mayfrank E, Daumann J, Becker B (2012). Increased gray matter density in patients with schizophrenia and cannabis use: A voxel-based morphometric study using DARTEL. Schizophrenia research 138, 183-187

Schoenmakers TM, Wiers RW (2009). Craving and Attentional Bias Respond Differently to Alcohol Priming: A Field Study in the Pub. European addiction research 16, 9-16

Schouw ML, De Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L (2012). Dopaminergic dysfunction in abstinent dexamphetamine users: Results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug and alcohol dependence 130, 52-60

Schweinsburg AD, Schweinsburg BC, Medina KL, McQueeny T, Brown SA, Tapert SF (2010). The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. Journal of psychoactive drugs 42, 401-412

Seeman P (2002). Atypical antipsychotics: mechanism of action. Canadian journal of psychiatry 47, 27-38

Ségonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004). A hybrid approach to the skull stripping problem in MRI. NeuroImage 22, 1060-1075

Segonne F, Pacheco J, Fischl B (2007). Geometrically Accurate Topology-Correction of Cortical Surfaces Using Nonseparating Loops. Medical Imaging, IEEE Transactions on 26, 518-529

Selivonchick DP, Johnston PV (1975). Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. The Journal of nutrition 105, 288-300

Severtson SG, Von Thomsen S, Hedden SL, Latimer W (2010). The association between executive functioning and motivation to enter treatment among regular users of heroin and/or cocaine in Baltimore, MD. Addictive Behaviors 35, 717-720

Shahand S, Santcroos M, van Kampen AHC, Olabarriaga SD (2012). A Grid-Enabled Gateway for Biomedical Data Analysis. Journal of Grid Computing, 1-18

Shenton ME, Dickey CC, Frumin M, McCarley RW (2001). A review of MRI findings in schizophrenia. Schizophrenia research 49, 1-52

Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012). Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neuroscience and biobehavioral reviews 36, 1342-1356

Sherer MA, Kumor KM, Jaffe JH (1989). Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry research 27, 117-125

Shiels K, Hawk Jr LW (2010). Self-regulation in ADHD: The role of error processing. Clinical psychology review 30, 951-961

Simmonds DJ, Pekar JJ, Mostofsky SH (2008). Meta-analysis of Go/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent. Neuropsychologia 46, 224-232

Simon JJ, Biller A, Walther S, Roesch-Ely D, Stippich C, Weisbrod M, Kaiser S (2010). Neural correlates of reward processing in schizophrenia--relationship to apathy and depression. Schizophrenia research 118, 154-161

Siris SG (1990). Pharmacological treatment of substance-abusing schizophrenic patients. Schizophrenia bulletin 16, 111

231

Sled JG, Zijdenbos AP, Evans AC (1998). A nonparametric method for automatic correction of intensity nonuniformity in MRI data. Medical Imaging, IEEE Transactions on 17, 87-97

Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M (2004). A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. Journal of substance abuse treatment 27, 45-49

Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R (2008). Pharmacological treatment of schizophrenia and co-occurring substance use disorders. CNS drugs 22, 903-916

Smesny S, Kinder D, Willhardt I, Rosburg T, Lasch J, Berger G, Sauer H (2005). Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia. Biological psychiatry 57, 399-405

Smesny S, Rosburg T, Baur K, Rudolph N, Sauer H (2007). Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 32, 2067-2073

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rossler A, Borgwardt SJ (2009). The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review. Current pharmaceutical design 15, 2535-2549

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31, 1487-1505

Sokhadze E, Stewart C, Hollifield M, Tasman A (2008). Event-Related Potential Study of Executive Dysfunctions in a Speeded Reaction Task in Cocaine Addiction. Journal of neurotherapy 12, 185-204

Solowij N, Walterfang M, Lubman DI, Whittle S, Lorenzetti V, Styner M, Velakoulis D, Pantelis C, Yücel M (2013). Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophrenia research 143, 179-184

Sorg C, Manoliu A, Neufang S, Myers N, Peters H, Schwerthoffer D, Scherr M, Muhlau M, Zimmer C, Drzezga A, Forstl H, Bauml J, Eichele T, Wohlschlager AM, Riedl V (2013). Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia. Schizophrenia bulletin 39, 387-395

Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA (2006). Brain volume in first-episode schizophrenia. The British Journal of Psychiatry 188, 510-518

Stroop JR (1935). . Studies of interference in serial verbal reactions

Stroop JR (1992). Studies of interference in serial verbal reactions. Journal of Experimental Psychology 121, 15-23

Sun J, Maller JJ, Guo L, Fitzgerald PB (2009). Superior temporal gyrus volume change in schizophrenia: A review on Region of Interest volumetric studies. Brain Research Reviews 61, 14-32

Szeszko PR, Robinson DG, Sevy S, Kumra S, Rupp CI, Betensky JD, Lencz T, Ashtari M, Kane JM, Malhotra AK (2007). Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. The British Journal of Psychiatry 190, 230-236

Szeszko PR, Robinson DG, Ashtari M, Vogel J, Betensky J, Sevy S, Ardekani BA, Lencz T, Malhotra AK, McCormack J, Miller R, Lim KO, Gunduz-Bruce H, Kane JM, Bilder RM (2008). Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 33, 976-984

Takagi M, Lubman DI, Cotton S, Fornito A, Baliz Y, Tucker A, Yuecel M (2011). Executive control among adolescent inhalant and cannabis users. Drug and Alcohol Review 30, 629-637

Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT, Frank LR (2007). Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology 194, 173-183 &

232

Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S (2004). Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. The American Journal of Psychiatry 161, 1620-1625

TENALEA I . Project.ALEA Randomisation Software (Version 2.2)[Computer Software].Amsterdam: Netherlands Cancer Institute, 2006

Thomason ME, Thompson PM (2011). Diffusion imaging, white matter, and psychopathology. Annual review of clinical psychology 7, 63-85

Thut G, Schultz W, Roelcke U, Nienhusmeier M, Missimer J, Maguire RP, Leenders KL (1997). Activation of the human brain by monetary reward. Neuroreport 8, 1225-1228

Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). The Lancet 374, 620-627

Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805

Tomasi D, Volkow ND (2012). Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Critical reviews in biochemistry and molecular biology 48, 1-19

Trapp BD, Bernsohn J (1978). Essential fatty acid deficiency and CNS myelin. Biochemical and morphological observations. Journal of the neurological sciences 37, 249-266

Tsuang JW, Eckman T, Marder S, Tucker D (2002). Can risperidone reduce cocaine use in substance abusing schizophrenic patients?. Journal of clinical psychopharmacology 22, 629-630

Tsuang J, Eckman T, Shaner A, Marder S (1999). Clozapine for substance-abusing schizophrenic patients. American Journal of Psychiatry 156, 1119a-1120

Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15, 273-289

Van Boxtel GJ, Van der Molen MW, Jennings JR, Brunia CH (2001). A psychophysiological analysis of inhibitory motor control in the stop-signal paradigm. Biological psychology 58, 229-262

Van den Brink W, Van Ree JM (2003). Pharmacological treatments for heroin and cocaine addiction. European neuropsychopharmacology 13, 476-487

van der Meer FJ, Velthorst E, Meijer CJ, Machielsen MW, de Haan L (2012). Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis. Current pharmaceutical design

van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W (2012). Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study. Schizophrenia research 137, 50-57

Van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF (2010). Chronic effects of cannabis use on the human reward system: an fMRI study. European neuropsychopharmacology 20, 153-163

Van Holst RJ, Van den Brink W, Veltman DJ, Goudriaan AE (2010). Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling. Neuroscience and biobehavioral reviews 34, 87-107

Van Holst RJ, Van Holstein M, Van den Brink W, Veltman DJ, Goudriaan AE (2012). Response inhibition during cue reactivity in problem gamblers: an fMRI study. PloS one 7, e30909

van Holst RJ, Veltman DJ, Buchel C, van den Brink W, Goudriaan AE (2012). Distorted expectancy coding in problem gambling: is the addictive in the anticipation?. Biological psychiatry 71, 741-748

Van Nimwegen LJ, De Haan L, Van Beveren NJ, Van Der Helm M, Van Den Brink W, Linszen D (2008). Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with

233

schizophrenia or related disorders: a double-blind randomized controlled trial. Canadian journal of psychiatry 53, 400-405

van Noordt SJ, Segalowitz SJ (2012). Performance monitoring and the medial prefrontal cortex: a review of individual differences and context effects as a window on self-regulation. Frontiers in human neuroscience 6

van Os J, Kenis G, Rutten BP (2010). The environment and schizophrenia. Nature 468, 203-212

Van Veen V, Carter CS (2002). The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiology & Behavior 77, 477-482

Verbruggen F, Logan GD (2008). Response inhibition in the stop-signal paradigm. Trends in cognitive sciences 12, 418-424

Verdejo-Garcia A, Lawrence AJ, Clark L (2008). Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and biobehavioral reviews 32, 777-810

Verheul R, van den Brink W, Geerlings P (1999). A three-pathway psychobiological model of craving for alcohol. Alcohol and Alcoholism (Oxford, Oxfordshire) 34, 197-222

Versace F, Engelmann JM, Jackson EF, Costa VD, Robinson JD, Lam CY, Minnix JA, Brown VL, Wetter DW, Cinciripini PM (2011). Do brain responses to emotional images and cigarette cues differ? An fMRI study in smokers. The European journal of neuroscience 34, 2054-2063

Virtanen JK, Siscovick DS, Longstreth WT,Jr, Kuller LH, Mozaffarian D (2008). Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 71, 439-446

Vita A, De Peri L, Silenzi C, Dieci M (2006). Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies. Schizophrenia research 82, 75-88

Vita A, Peri L, Turrina C, Sacchetti E (2011). Brain Morphological Abnormalities at the Onset of Schizophrenia and Other Psychotic Disorders: A Review of the Evidence. In Handbook of Schizophrenia Spectrum Disorders, Volume I (ed. M. S. Ritsner), pp. 431-443. Springer Netherlands

Volkow ND, Fowler JS (2000). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cerebral cortex 10, 318-325

Volkow ND, Fowler JS, Wang GJ (2004). The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 47 Suppl 1, 3-13

Volkow ND, Fowler JS, Wang GJ (1999). Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. Journal of psychopharmacology 13, 337-345

Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004). Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Molecular psychiatry 9, 557-569

Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007). Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Archives of Neurology 64, 1575-1579

Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR (1999). Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. The Journal of pharmacology and experimental therapeutics 291, 409-415

Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C (2006). Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. The Journal of neuroscience 26, 6583-6588

Volkow ND, Wang GJ, Tomasi D, Baler RD (2012). Obesity and addiction: neurobiological overlaps. Obesity reviews 14, 2-18

Vollstadt-Klein S, Loeber S, Richter A, Kirsch M, Bach P, Von der Goltz C, Hermann D, Mann K, Kiefer F (2012). Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addiction Biology 17, 807-816 &

234

Voruganti LN, Awad AG (2006). Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study. Schizophrenia research 88, 179-186

Wachtel SR, Ortengren A, Wit Hd (2002). The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug and alcohol dependence 68, 23-33

Walter H, Kammerer H, Frasch K, Spitzer M, Abler B (2009). Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia. Psychopharmacology 206, 121-132

Waltz JA, Frank MJ, Robinson BM, Gold JM (2007). Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biological psychiatry 62, 756-764

Waltz JA, Schweitzer JB, Ross TJ, Kurup PK, Salmeron BJ, Rose EJ, Gold JM, Stein EA (2010). Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 35, 2427-2439

Wang G, Volkow ND, Fowler JS (2002). The role of dopamine in motivation for food in humans: implications for obesity. Expert opinion on therapeutic targets 6, 601-609

Waters AJ, Shiffman S, Bradley BP, Mogg K (2003). Attentional shifts to smoking cues in smokers. Addiction (Abingdon, England) 98, 1409-1417

Wessel JR, Danielmeier C, Ullsperger M (2011). Error awareness revisited: accumulation of multimodal evidence from central and autonomic nervous systems. Journal of cognitive neuroscience 23, 3021-3036

Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, Gore JC (2001). Functional magnetic resonance imaging of cocaine craving. The American Journal of Psychiatry 158, 86-95

Wierenga LM, Langen M, Oranje B, Durston S (2013). Unique developmental trajectories of cortical thickness and surface area. NeuroImage

Wilkinson D, Halligan P (2004). The relevance of behavioural measures for functional-imaging studies of cognition. Nature reviews.Neuroscience 5, 67-73

Williams LM (2008). Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect. Expert review of neurotherapeutics 8, 1049-1065

Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J (2000). Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. Journal of Addictive Diseases 19, 1-22

Wines JD, Weiss RD (1999). Opioid withdrawal during risperidone treatment. Journal of clinical psychopharmacology 19, 265-267

Wing JK, Babor T, Brugha T, Burke J, Cooper J, Giel R, Jablenski A, Regier D, Sartorius N (1990). SCAN: Schedules fonr Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47, 589

Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov LG, Gaebel W, Fleischhacker WW, EUFEST study group (2013). Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia research 147, 132-139

Wobrock T, Soyka M (2008). Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations. Progress in neuro-psychopharmacology & biological psychiatry 32, 1375-1385

Wobrock T, Czesnik D, Malchow B (2011). Schizophrenia and Comorbid Substance Abuse Pathophysiological and Therapeutic Approaches. In (ed. M. S. Ritsner), pp. 321-363. Springer Netherlands

Wobrock T, Sittinger H, Behrendt B, D’Amelio R, Falkai P (2009). Comorbid substance abuse and brain morphology in recent-onset psychosis. European archives of psychiatry and clinical neuroscience 259, 28-36

235

Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996). A unified statistical approach for determining significant signals in images of cerebral activation. Human brain mapping 4, 58-73

Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, Kahnt T, Beck A, Strohle A, Juckel G, Knutson B, Heinz A (2007). Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage 35, 787-794

Yacubian J, Glascher J, Schroeder K, Sommer T, Braus DF, Buchel C (2006). Dissociable systems for gain- and loss-related value predictions and errors of prediction in the human brain. The Journal of neuroscience : the official journal of the Society for Neuroscience 26, 9530-9537

Yalachkov Y, Kaiser J, Naumer MJ (2010). Sensory and motor aspects of addiction. Behavioural brain research 207, 215-222

Yang B, Yang S, Zhao L, Yin L, Liu X, An S (2009). Event-related potentials in a Go/Nogo task of abnormal response inhibition in heroin addicts. Science in China.Series C, Life sciences 52, 780-788

Yao JK, Stanley JA, Reddy RD, Keshavan MS, Pettegrew JW (2002). Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biological psychiatry 52, 823-830

Yao JK, Leonard S, Reddy RD (2000). Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophrenia research 42, 7-17

Yao JK, van Kammen DP (2004). Membrane phospholipids and cytokine interaction in schizophrenia. International review of neurobiology 59, 297-326

Yovell Y, Opler LA (1994). Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: A case report and a hypothesis. Journal of Nervous and Mental Disease 182, 591--2

Yücel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia bulletin 38, 316-330

Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003). Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophrenia research 60, 21-32

Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2008). Effects of cannabis use on outcomes of psychotic disorders: systematic review. The British journal of psychiatry 193, 357-363

Zhou Z, Yuan G, Yao J, Li C, Cheng Z (2010). An event-related potential investigation of deficient inhibitory control in individuals with pathological Internet use. Acta Neuropsychiatrica 22, 228-236

Zijlstra F, Veltman DJ, Booij J, van den Brink W, Franken IH (2009). Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug and alcohol dependence 99, 183-192

Zimmet SV, Strous RD, Burgess ES, Kohnstamm S, Green AI (2000). Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. Journal of clinical psychopharmacology 20, 94-98

&